---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-011380"
form_type: "8-K"
ticker: "NXTS"
cik: "0001789192"
company_name: "Nexentis Technologies Inc."
filed_at: "2025-07-24T23:59:59+00:00"
generated_at: "2026-05-18T02:29:14.467955+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# N2OFF amends MitoCareX acquisition: extends closing deadline, updates share counts and consideration caps

## Summary
- Outside Date extended by 90 days to 270 days from original agreement date (Feb 25, 2025).
- Fully-diluted share count updated to 32,808,629 (from 27,734,248) to reflect issuances after execution.
- Additional consideration for sellers capped at $1.6M total, allocated 52.73% SciSparc, 31.51% Alon, 15.76% Ciro.
- Post-closing N2OFF shares outstanding projected at 56,939,836, up from current 30,096,412 (increase ~26.8M).
- Milestone-based Additional Purchaser Stock of up to 25% of post-closing fully-diluted capital, vesting by Dec 31, 2028.

## SEC filing metadata
- accession: 0001493152-25-011380
- form_type: 8-K
- ticker: NXTS
- cik: 0001789192
- company_name: Nexentis Technologies Inc.
- filed_at: 2025-07-24T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1789192/000149315225011380/0001493152-25-011380-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1789192/000149315225011380/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-011380
- JSON: https://secwatch.observer/filing/0001493152-25-011380.json
- Plain text: https://secwatch.observer/filing/0001493152-25-011380.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
